FABIO: TWAS fine-mapping to prioritize causal genes for binary traits
PLOS Genetics · 2024
DOI: 10.1371/journal.pgen.1011503 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Genetics, 2024. Verfasst von Haihan Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, United States of America. Hauptthemen laut MEDLINE: Genome-Wide Association Study, Quantitative Trait Loci, Chromosome Mapping. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NIGMS NIH HHS, NHGRI NIH HHS.
Abstract (Originalsprache)
Transcriptome-wide association studies (TWAS) have emerged as a powerful tool for identifying gene-trait associations by integrating gene expression mapping studies with genome-wide association studies (GWAS). While most existing TWAS approaches focus on marginal analyses through examining one gene at a time, recent developments in TWAS fine-mapping methods enable the joint modeling of multiple genes to refine the identification of potentially causal ones. However, these fine-mapping methods have primarily focused on modeling quantitative traits and examining local genomic regions, leading to potentially suboptimal performance. Here, we present FABIO, a TWAS fine-mapping method specifically designed for binary traits that is capable of modeling all genes jointly on an entire chromosome. FABIO employs a probit model to directly link the genetically regulated expression (GReX) of genes to binary outcomes while taking into account the GReX correlation among all genes residing on a chromosome. As a result, FABIO effectively controls false discoveries while offering substantial power gains over existing TWAS fine-mapping approaches. We performed extensive simulations to evaluate the performance of FABIO and applied it for in-depth analyses of six binary disease traits in the UK Biobank. In the real datasets, FABIO significantly reduced the size of the causal gene sets by 27.9%-36.9% over existing approaches across traits. Leveraging its improved power, FABIO successfully prioritized multiple potentially causal genes associated with the diseases, including GATA3 for asthma, ABCG2 for gout, and SH2B3 for hypertension. Overall, FABIO represents an effective tool for TWAS fine-mapping of disease traits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, United States of America.
- Department of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.
- Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, United States of America.
ORCID-Profile: Haihan Zhang, Kevin He, Zheng Li, Xiang Zhou
Förderung
- NIAMS NIH HHS
- NIGMS NIH HHS
- NHGRI NIH HHS
- Foundation for the National Institutes of Health
Zitieren
APA
Zhang, H., He, K., Li, Z., Tsoi, L. C., & Zhou, X. (2024). FABIO: TWAS fine-mapping to prioritize causal genes for binary traits. PLOS Genetics. https://doi.org/10.1371/journal.pgen.1011503
Vancouver
Zhang H, He K, Li Z, Tsoi LC, Zhou X. FABIO: TWAS fine-mapping to prioritize causal genes for binary traits. PLOS Genetics. 2024. doi:10.1371/journal.pgen.1011503
BibTeX
@article{Zhang2024,
author = {Zhang, Haihan and He, Kevin and Li, Zheng and Tsoi, Lam C and Zhou, Xiang},
title = {FABIO: TWAS fine-mapping to prioritize causal genes for binary traits},
journal = {PLOS Genetics},
year = {2024},
doi = {10.1371/journal.pgen.1011503}
}
EUVIMED